Resmed Inc.
RMD
Market Cap$26.98B
Close$
$173.62
20.4% downside
Current Fair Value
20.4% downsideOvervalued by 20.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $26.98 Billion |
|---|---|
| Enterprise Value | $28.00 Billion |
| Dividend Yield | $1.8724 (1.02%) |
| Earnings per Share | $6.03 |
| Beta | 0.0 |
| Outstanding Shares | 147,088,888 |
| Avg 30 Day Volume | 1,084,058 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 30.3 |
|---|---|
| PEG | -422.92 |
| Price to Sales | 7.27 |
| Price to Book Ratio | 7.27 |
| Enterprise Value to Revenue | 6.22 |
| Enterprise Value to EBIT | 22.35 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.27 |
Revenue Sources
No data
ESG Score
No data
About Resmed Inc.
CEO: Michael Farrell